Leading plasmid DNA CDMO VGXI, Inc. announces the appointment of Jeff Whitmore as its new Chief Commercial Officer. VGXI Inc., a distinguished Texas-based Contract Development and Manufacturing Organization (CDMO) specializing in the production of plasmid DNA and RNA biopharmaceuticals, is pleased to announce the appointment of Mr. Jeff Whitmore as Chief Commercial… Read More »
The ISV Annual Congress is the world’s largest scientific conference in the field of vaccines and covers a broad range of topics related to vaccines and immunotherapies. We welcome you to stop by VGXI’s booth or schedule a meeting with one of our representatives during the conference to learn more about VGXI’s plasmid manufacturing… Read More »
The 26th International Symposium on Hepatitis C Virus and Related Viruses focuses on the advancement of HCV and related virus research, vaccines, and therapies. We welcome you to stop by VGXI’s booth or schedule a meeting with one of our representatives during the conference to learn more about VGXI’s plasmid manufacturing services and experience!… Read More »
The Cell & Gene Meeting on the Mesa is a three-day conference bringing together senior executives and top decision-makers in the industry with the scientific community to advance cutting-edge research into cures. Be sure to stop by VGXI’s booth or schedule a meeting with one of our representatives during the conference to learn how VGXI’s… Read More »
Industry recognized plasmid DNA manufacturer VGXI, Inc. to support production of personalized cancer therapies as part of a long-term supply agreement with Geneos Therapeutics. June 22, 2019, The Woodlands, TX and Plymouth Meeting, PA – Plasmid CMO VGXI, Inc. and Geneos Therapeutics, Inc., a spin-out of Inovio Pharmaceuticals (NASDAQ: INO) focused on developing… Read More »
A new and completely redesigned website offers visitors a comprehensive overview of VGXI’s range of plasmid DNA manufacturing services and capabilities. May 20, 2019, The Woodlands, TX – Texas based CMO VGXI, Inc., which specializes in production of DNA plasmid biopharmaceuticals, announced it has gone live with a refreshed website and online… Read More »
With over 16,000 attendees, BIO is one of the largest biotech partnering, education, and networking events in the world. Be sure to stop by VGXI’s Booth #3349 or schedule a meeting with one of our representatives during the conference to learn how VGXI’s plasmid manufacturing services can support your gene or cell therapy program! Contact Us directly… Read More »
Plasmid CMO VGXI will be speaking at the 22nd Annual ASGCT Meeting in Washington DC. April 04, 2019, The Woodlands, TX – VGXI, Inc., an industry leading plasmid DNA contract manufacturing organization today announced that Mr. Stephen Rodriguez, Sr. Manager, Process Development, will be presenting during the Tools and Technologies Forum of… Read More »
The American Society of Gene and Cell Therapy (ASGCT) Annual Meeting provides an international forum where the latest gene and cell therapy developments are presented and critically discussed. Visit VGXI’s Booth #411 or meet with one of our representatives during the conference to learn more about how our plasmid manufacturing services can support your gene or… Read More »
Texas based CMO VGXI Announces Completion of Initial Tech Transfer Milestones as part of its Partnership Agreement for Production of RNA Therapeutics with HMRI. March 15, 2019, The Woodlands, TX – Under a license agreement with the Houston Methodist Research Institute (HMRI) for development of clinical grade RNA manufacturing services, VGXI announced… Read More »
The World Vaccine Congress is a critical strategic partnering event for the global vaccine industry. Visit our Booth #413 or meet with a representative from VGXI during the conference in April to learn more about how our plasmid manufacturing services can support your vaccine program! We welcome meeting requests through the WVC partnering… Read More »
Gene Therapy for Rare Disorders focuses exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market. Meet with a representative from VGXI during the conference to learn more about how our plasmid manufacturing services can support your gene therapy products! Contact Us today to schedule a meeting time…. Read More »
Combined with the World Stem Cell Summit, Phacilitate Leaders World is the worlds largest advanced therapies partnering event. Stop by VGXI’s Booth # 713 to meet with representatives from our company and learn more about our plasmid manufacturing products and services! We welcome meeting requests through the Phacilitate partnering website, or contact Us today to schedule… Read More »